Menu
Back to User profile » Prof. Dr. Jean Nachega
Papers published by Prof. Dr. Jean Nachega:
Acceptability and feasibility of mHealth and community-based directly observed antiretroviral therapy to prevent mother-to-child HIV transmission in South African pregnant women under Option B+: an exploratory study
Nachega JB, Skinner D, Jennings L, Magidson JF, Altice FL, Burke JG, Lester RT, Uthman OA, Knowlton AR, Cotton MF, Anderson JR, Theron GB
Patient Preference and Adherence 2016, 10:683-690
Published Date: 28 April 2016
Risk factors for suboptimal antiretroviral therapy adherence in HIV-infected adolescents in Gaborone, Botswana: a pilot cross-sectional study
Ndiaye M, Nyasulu P, Nguyen H, Lowenthal ED, Gross R, Mills EJ, Nachega JB
Patient Preference and Adherence 2013, 7:891-895
Published Date: 11 September 2013
Boceprevir and telaprevir for the treatment of chronic hepatitis C genotype 1 infection: an indirect comparison meta-analysis
Cooper CL, Druyts E, Thorlund K, Nachega JB, El Khoury AC, O'Regan C, Mills EJ
Therapeutics and Clinical Risk Management 2012, 8:105-130
Published Date: 9 March 2012
Twice-daily versus once-daily antiretroviral therapy and coformulation strategies in HIV-infected adults: benefits, risks, or burden?
Nachega JB, Rosenkranz B, Pham PA
Patient Preference and Adherence 2011, 5:645-651
Published Date: 28 December 2011
Treatment simplification in HIV-infected adults as a strategy to prevent toxicity, improve adherence, quality of life and decrease healthcare costs
Nachega JB, Mugavero MJ, Zeier M, Vitória M, Gallant JE
Patient Preference and Adherence 2011, 5:357-367
Published Date: 18 July 2011